HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ABBISKO-B

14.320

+0.6304.60%

Volume:1.04M

Turnover:14.66M

Market Cap:9.62B

PE:290.76

High:14.320

Open:13.760

Low:13.690

Close:13.690

52wk High:19.780

52wk Low:4.200

Shares:672.00M

HK Float Shares:672.00M

Volume Ratio:0.78

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.049

ROE:6.88%

ROA:2.27%

PB:3.92

PE(LYR):290.76

PS:14.09

Loading ...

Overview Company News Filings

ABBISKO-B (02256): Abbisko Announces Phase II Clinical Preliminary Results of Oral PD-L1 Inhibitor ABSK043 Combined with EGFR Inhibitor Furmonertinib for NSCLC at ESMO Asia 2025

Abbisko Cayman Reports Positive Phase II Results for Oral PD-L1 Inhibitor ABSK043 in NSCLC Combination Therapy

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Abbisko Cayman (02256) Releases Monthly Return for November 2025

Bulletin Express

Abbisko's IND Application for Cancer Therapy Cleared by U.S. FDA

MT Newswires Live

BRIEF-Abbisko Cayman Says U.S. FDA Clears IND Application For ABSK141

ABBISKO-B (02256): FDA Approves IND Application for Oral Small Molecule KRAS G12D Inhibitor ABSK141

Abbisko Cayman - U.S. FDA Clears Ind Application for Abbisko's Absk141

THOMSON REUTERS

Abbisko Therapeutics Wins FDA IND Clearance for KRAS G12D Inhibitor

Is Abbisko Cayman Limited (HKG:2256) Trading At A 39% Discount?

Simply Wall St.

ABBISKO-B (02256) Rises Over 4% in Late Trading as It Presents Long-Term Efficacy and Safety Data of Pimicotinib in Phase III MANEUVER Study

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Abbisko Cayman Limited (2256) Reports Longer-Term Efficacy and Safety Data for Pimicotinib Phase III Study in TGCT

Bulletin Express

ABBISKO-B (02256): Subsidiary ABBISKO Presents Long-Term Efficacy and Safety Data of Pimicotinib Phase III MANEUVER Study at CTOS 2025 Annual Meeting

Abbisko Cayman Reports Positive Long-Term Results for Pimicotinib in Phase III TGCT Study

ABBISKO-B (02256) Completes First Patient Dosing in Phase II Clinical Trial of Oral Small-Molecule PD-L1 Inhibitor ABSK043 Combined with Golecerase for NSCLC Treatment

Abbisko Therapeutics Doses First Patient in Phase II NSCLC Study

Exploring the Depth and Breadth of ABBISKO-B's (02256) FIC/BIC Innovation Pipeline at R&D Day

Guoyuan International Initiates Buy Rating on ABBISKO-B (02256) with Target Price of HK$22.06

Hong Kong Stock Movement | ABBISKO-B (02256) Surges Over 7% Amid Presentation of Pimicotinib Phase III Study Data at 2025 ESMO Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02256/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"ABBISKO-B","latestPrice":14.32,"timestamp":1765526889004,"preClose":13.69,"halted":0,"volume":1044000,"delay":0,"floatShares":672000000,"shares":672000000,"eps":0.04925099299392807,"marketStatus":"Not Yet Opened","change":0.63,"latestTime":"12-12 16:08:09","open":13.76,"high":14.32,"low":13.69,"amount":14664407,"amplitude":0.046019,"askPrice":14.32,"askSize":7000,"bidPrice":14.1,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.24569890537132183,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":0,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":13.69,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.7777034506725258,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":672000000,"roa":"2.27%","roe":"6.88%","lyrEps":0.049251,"volumeRatio":0.7777034506725258,"shares":672000000,"dividePrice":0,"high":14.32,"amplitude":0.046019,"preClose":13.69,"low":13.69,"week52Low":4.2,"pbRate":"3.92","psRate":"14.09","week52High":19.78,"institutionHeld":0,"latestPrice":14.32,"committee":-0.75,"eps":0.04925099299392807,"divideRate":0,"volume":1044000,"delay":0,"ttmEps":0.24569890537132183,"open":13.76,"prevYearClose":4.6,"prevWeekClose":14.32,"prevMonthClose":14.3,"prevQuarterClose":17.92,"fiveDayClose":14.2,"twentyDayClose":14.7,"sixtyDayClose":17.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2025-08-04","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754271000000,"name":null,"time":"","dateTimestamp":1754236800000,"actualEps":null},{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"Post Market","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"Post Market","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null},{"date":"2023-08-15","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692063000000,"name":null,"time":"","dateTimestamp":1692028800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1762272000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2025-12-12","current":58.282718,"percent":0.832847,"low":-234.512257,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"high":254.727882,"avg":2.305286,"sd":83.590318,"marketCap":9628214532},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796},{"date":"2025-04-25","current":157.525338,"twenty":-7.035077,"median":-3.06483,"eighty":-1.297429,"marketCap":4745757129},{"date":"2025-05-02","current":164.646937,"twenty":-6.98082,"median":-3.059687,"eighty":-1.294598,"marketCap":4970852329},{"date":"2025-05-09","current":160.887021,"twenty":-6.966007,"median":-3.058035,"eighty":-1.289956,"marketCap":4891435796},{"date":"2025-05-16","current":166.920406,"twenty":-6.956944,"median":-3.054843,"eighty":-1.284736,"marketCap":5116329396},{"date":"2025-05-23","current":172.811396,"twenty":-6.918805,"median":-3.051744,"eighty":-1.280509,"marketCap":5312740129},{"date":"2025-05-30","current":194.14447,"twenty":-6.859825,"median":-3.047185,"eighty":-1.269715,"marketCap":5994823373},{"date":"2025-06-06","current":193.852557,"twenty":-6.827912,"median":-3.029734,"eighty":-1.263923,"marketCap":6001081017},{"date":"2025-06-13","current":206.909864,"twenty":-6.817054,"median":-3.027014,"eighty":-1.258681,"marketCap":6407827906},{"date":"2025-06-20","current":226.129725,"twenty":-6.80981,"median":-3.021411,"eighty":-1.253542,"marketCap":6989324733},{"date":"2025-06-27","current":219.382855,"twenty":-6.774951,"median":-3.010594,"eighty":-1.249178,"marketCap":6799778035},{"date":"2025-07-04","current":207.131321,"twenty":-6.751721,"median":-3.004715,"eighty":-1.245928,"marketCap":6420343195},{"date":"2025-07-11","current":194.227376,"twenty":-6.748553,"median":-2.997106,"eighty":-1.23779,"marketCap":6014301773},{"date":"2025-07-18","current":239.206864,"twenty":-6.742193,"median":-2.992401,"eighty":-1.233081,"marketCap":7401298850},{"date":"2025-07-25","current":223.606361,"twenty":-6.733962,"median":-2.987644,"eighty":-1.227416,"marketCap":6943764012},{"date":"2025-08-01","current":221.508288,"twenty":-6.720681,"median":-2.97652,"eighty":-1.21075,"marketCap":6836108756},{"date":"2025-08-08","current":50.470458,"twenty":-6.69485,"median":-2.968177,"eighty":-1.205206,"marketCap":8274964605},{"date":"2025-08-15","current":65.75115,"twenty":-6.664055,"median":-2.960553,"eighty":-1.200737,"marketCap":10764181600},{"date":"2025-08-22","current":69.328024,"twenty":-6.623327,"median":-2.952385,"eighty":-1.196881,"marketCap":11314163907},{"date":"2025-08-29","current":70.197956,"twenty":-6.58783,"median":-2.944688,"eighty":-1.195394,"marketCap":11510826312},{"date":"2025-09-05","current":74.741403,"twenty":-6.545813,"median":-2.931892,"eighty":-1.193197,"marketCap":12243700183},{"date":"2025-09-12","current":74.279336,"twenty":-6.493001,"median":-2.918097,"eighty":-1.190811,"marketCap":12189911275},{"date":"2025-09-19","current":71.544121,"twenty":-6.455769,"median":-2.873353,"eighty":-1.179252,"marketCap":11732705557},{"date":"2025-09-26","current":69.674923,"twenty":-6.40006,"median":-2.852194,"eighty":-1.166431,"marketCap":11396524882},{"date":"2025-10-03","current":74.307,"twenty":-6.312512,"median":-2.838066,"eighty":-1.159178,"marketCap":12183187662},{"date":"2025-10-10","current":70.431829,"twenty":-6.288573,"median":-2.801814,"eighty":-1.154706,"marketCap":11530997152},{"date":"2025-10-17","current":63.17088,"twenty":-6.157723,"median":-2.769702,"eighty":-1.141961,"marketCap":10334193949},{"date":"2025-10-24","current":58.25878,"twenty":-5.928147,"median":-2.735891,"eighty":-1.138284,"marketCap":9534083943},{"date":"2025-10-31","current":59.730926,"twenty":-5.921366,"median":-2.711752,"eighty":-1.135193,"marketCap":9789581256},{"date":"2025-11-07","current":58.126276,"twenty":-5.917138,"median":-2.68435,"eighty":-1.120838,"marketCap":9520636716},{"date":"2025-11-14","current":60.172448,"twenty":-5.914987,"median":-2.645577,"eighty":-1.113983,"marketCap":9883711845},{"date":"2025-11-21","current":53.525201,"twenty":-5.81235,"median":-2.567515,"eighty":-1.103539,"marketCap":8787762844},{"date":"2025-11-28","current":58.350437,"twenty":-5.778066,"median":-2.550052,"eighty":-1.098391,"marketCap":9614767305},{"date":"2025-12-05","current":57.842944,"twenty":-5.775395,"median":-2.509912,"eighty":-1.092946,"marketCap":9547531170},{"date":"2025-12-12","current":58.224062,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"marketCap":9628214532}],"updateTime":1765742982563},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143546404","title":"ABBISKO-B (02256): Abbisko Announces Phase II Clinical Preliminary Results of Oral PD-L1 Inhibitor ABSK043 Combined with EGFR Inhibitor Furmonertinib for NSCLC at ESMO Asia 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1143546404","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143546404?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:10","pubTimestamp":1765152630,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced on December 8, 2025, that Shanghai Abbisko Biotechnology Co., Ltd. (Abbisko) presented positive preliminary results from the dose-escalation phase of its Phase II clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","LU1169589451.USD","LU1169590202.USD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1574","BK4023","BK1515","LU2476274308.USD","IE00B543WZ88.USD","LU2476274720.SGD","PD","IE00BPRC5H50.USD","02256","LU2488822045.USD","09939","BK1161"],"gpt_icon":0},{"id":"2589780126","title":"Abbisko Cayman Reports Positive Phase II Results for Oral PD-L1 Inhibitor ABSK043 in NSCLC Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2589780126","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589780126?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:00","pubTimestamp":1765152045,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited announced the preliminary results from the dose escalation phase of its ongoing Phase II clinical study evaluating the oral small-molecule PD-L1 inhibitor ABSK043 in combination with the third-generation EGFR-TKI, firmonertinib, for the treatment of non-small cell lung cancer . The data, presented at the European Society for Medical Oncology Asia Congress 2025 , indicated that the combination therapy demonstrated favorable safety and tolerability. Regulatory authorities have agreed to expand the program into a first-line study in treatment-nave patients with EGFR mutated, PD-L1 positive NSCLC. Abbisko Cayman Limited noted that there is no guarantee that ABSK043 will ultimately be successfully marketed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8R1FVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","IE00BPRC5H50.USD","LU2476274308.USD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1161","LU2476274720.SGD","LU2778985437.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU1102505762.USD","BK1100","BK1221","LU0228659784.USD","BK1160","SG9999015945.SGD","BK1209","LU0572944931.SGD","LU1969619763.USD","BK1158","BK1606","LU0048575426.USD","LU0164872284.USD","LU1497733557.USD","LU0039217434.USD","LU0594300419.USD","LU2543165471.USD","06168","03998","02020","01939","BK1556","06657","IE00BQXX3D17.EUR","03658","IE00BQXX3C00.GBP","IE00BGV7N243.SGD","LU0540923850.HKD","SGXZ62798434.SGD","01530","BK1589","LU2357125470.USD","SGXZ86797644.SGD","BK1207","09877","LU0737861699.HKD","02451","BK1155","BK1554","SG9999014674.SGD","01093","02469","LU0345776255.USD","LU0823426480.USD","03800","HK0000252152.HKD","LU1720050803.USD","LU0708995583.HKD","LU1861219969.SGD","LU1366334651.USD","06633","LU0348825331.USD","LU2476274308.USD","01119","BK1527","HK0000306701.USD","LU0164865239.USD","BK1117","LU0509642566.USD","LU1224709979.USD","09660","BK1125","BK1214","LU1039395188.USD","09699","BK1516","80020","LU0823038988.USD","06090","BK1524","BK1617","IE00B8L5B284.USD","LU0175139822.USD","SG9999004311.SGD","LU1267930227.SGD","BK1608","02177","BK1591","LU0067412154.USD","LU1226288253.USD","LU1880383440.USD","LU0541502299.USD","LU1939255532.USD","LU0823397103.USD","01739","SG9999015986.USD","HK0000320223.HKD","LU1048588211.SGD","BK1604","LU0456827905.SGD","SG9999001226.SGD","LU1880383366.USD","02565","LU1235295612.USD","03709","BK1258","01384","SG9999015952.SGD","LU0310800965.SGD","LU0348827113.USD","LU1522347837.USD","LU1152091754.HKD","LU0348767384.USD","82331","00384","BK1190","03145","BK1195","LU0463099449.HKD","09690","00460","01519","BK1557","01880","002594","LU0880133367.SGD","LU1211504680.USD","06609","02392","LU0128525689.USD","LU1960683339.HKD","BK1227","00451","BK1164","00992","02331","06862","LU0561508036.HKD","BK1239","BK1240","IE0034224299.USD","02298","BK1571","LU0082770016.USD","LU0289739343.SGD","LU1497733631.SGD","BK1193","06996","03396","LU1981816686.USD","BK1542","HK0000252160.HKD","IE00BVYPNP33.GBP","LU0348805143.USD","SG9999001051.SGD","IE00B0JY6N72.USD","LU0370786039.SGD","06069","06186","01783","IE00BYV24P56.USD","LU0048580855.USD","LU0469268626.HKD","LU0314109678.HKD","00826","BK1520","ANPDY","02886","BK1564","BK1119","LU0164939612.USD","00305","LU0516422440.USD","LU0593848301.USD","01818","02145","BK1222","BK1574","BK1509","LU1226287875.USD","LU0605514214.HKD","09990","LU1008478684.HKD","02629","LU1102505929.USD","IE00BPRC5H50.USD","LU2097828631.EUR","LU2778985437.USD","02121","LU1861214812.USD","LU0819123356.HKD","BK1212","09955","IE0009570106.USD","01177","BK1178","00017","BK1237","06138","LU0634319403.HKD","LU0828237510.HKD","LU1188198961.HKD","BK1225","SG9999001903.USD","01440","02509","03680","02155","BK1541","BK1147","LU0501845795.SGD","BK1230","BK1521","09890","02171","SG9999015978.USD","01640","01211","02420","LU0511384066.AUD","LU0543330566.HKD","BK1179","09923","BK1502","LU0269904917.USD","IE00BZ08YT58.USD","BK1143","BK1515","LU2449936058.SGD","01907","02650","LU1366334578.USD","LU0417516902.SGD","BK1257","IE0003851619.USD","LU1675838814.USD","01735","BK1124","01952","02142","LU1956131251.USD","IE00BZ08YS42.EUR","LU2153592121.USD","LU0871576103.HKD","LU1023057109.AUD","06100","02419","LU0823414478.USD","LU0348783233.USD","BK1141","LU2097828805.USD","LU1634259391.SGD","00267","LU1226287529.USD","LU0214875030.USD","LU0516422952.EUR","LU0650527681.SGD","06618","LU0052756011.USD","LU0320764599.SGD","IE0003795394.USD","BK1253","IE00BZ08YR35.GBP","BK1613","LU0417516738.SGD","LU2663582299.SGD","01164","02268","LU2177674079.SGD","BK1168","LU1794554557.SGD","LU0011963245.USD","LNNGY","LU0261950470.USD","LU0588545490.SGD","01520","LU0856984785.SGD","LU0762540952.USD","09878","02380","BK1616","00382","LU0516422366.SGD","LU0072462343.USD","01809","LU0868486357.SGD","BK1544","LU3063872942.SGD","LU0516423091.SGD","LU2328871848.SGD","BK1593","HYDD.SI","LU1303224171.USD","LU0165289439.USD","01405","LU0164880469.USD","BK1560","06855","LU0499858602.USD","03677","09911","06608","02150","LU0828238088.HKD","BK1128","09678","LU0516423174.USD","SG9999002828.SGD","LU0737861772.HKD","LU0259732245.USD","BK1114","BK1200","BK1161","09926","02158","BK1597","BK1522","LU0702159699.USD","BK1566","02276","BK1134","02567","IE00B031HY20.USD","BK1183","BK1610","LU0052750758.USD","02696","01448","LU0326950275.SGD","01458","LU1868837565.USD","00135","09639","06677","00875","SG9999002950.SGD","LU1328615791.USD","HK0000306685.HKD","LU1166156734.SGD","LU1497734951.SGD","LU2045819591.USD","01117","BK1229","03836","LU1961090484.USD","09927","LU1481107354.HKD","02057","BK1618","LU2023250504.SGD","LU1226287792.SGD","LU1770036033.HKD","LU0572939691.SGD","03738","BK1539","SG9999011746.SGD","02595","LU0054450605.USD","IE00B5MMRT66.SGD","06683","00855","LU2242644610.SGD","BK1096","BK1609","LU1868838027.USD","LU2238339852.HKD","LU2294711713.HKD","02273","SG9999001069.SGD","LU2106854487.HKD","SG9999000459.SGD","IE00B543WZ88.USD","LU1770034418.SGD","00999","BK1111","09996","LU2097828557.USD","IE00BVYPNQ40.USD","LU2476274720.SGD","06919","BK1512","LU0823414551.USD","LU1282649067.USD","BK1531","BK1619","LU0287142896.SGD","LU0823426308.USD","00363","LU0315179316.USD","LU0431992006.USD","BK1559","BK1553","LU1868837722.USD","BK1144","LU0455707207.USD","02250","LU0327786744.USD","02460","IE0008369823.USD","LU0329678170.USD","LU0449515922.USD","LU0149721374.USD","LU0572940350.SGD","02096","BK1126","BK1220","LU0244354667.USD","BK1592","03896","LU0348735423.USD","LU1807302812.USD","LU0251143458.SGD","LU2249611893.SGD","LU1282649810.SGD","LU2039709279.SGD","LU1328277881.USD","01276","02157","00003","BK1110","02256","BK1578","LU0588545904.SGD","02411","LU0488056044.USD","BK1139","LU1242518931.SGD","LU0502904849.HKD","BK1528","LU0359201885.HKD","01833","BK1575","00960","02858","LU0289960550.SGD","LU0611395673.USD","LU0251144936.SGD","01333","BK1233","BK1163","BK1228","LU1974910355.USD","BK1518","BK1109","02167","06988","02552","03650","LU0048597586.USD","LU1993786604.SGD","09636","HK0000500386.USD","02556","BK1104","BK1594","03681","BK1526","LU2348773727.SGD","01651","BK1549","BK1540","BK1548","LU0449509016.USD","LU2008162690.USD","BK1167","LU0315178854.USD","82020","LU0620787316.HKD","02018","01969","02616","LU0819121731.USD","LU0289961442.SGD","00699","LU2360107325.USD","02598","BK1127","BK1188","BK1583","LU0211977185.USD","SG9999004220.SGD","LU2506952253.HKD","LU2153591404.USD","02315","02100","BK1550","LU0588546209.SGD","LU0791591158.USD","00656","IE00BQXX3F31.USD","LU0072913022.USD","LU2399975544.HKD","02279","IE00B0169L03.USD","LU0417516571.SGD","SG9999006597.SGD","BK1169","01585","LU0107464264.USD","BK1215","BK1504","BK1216","LU0348784397.USD","LU0307460666.USD","LU0348766576.USD","IE00B031J352.USD","LU0229945570.USD","LU0505663152.USD","LU0531971595.HKD","09919","02525","LU0140636845.USD","LU0143863784.USD","LU1634259557.SGD","BK1142","LU0359201612.USD","BK1194","LU0541501648.USD","00302","BK1595","LU1251922891.USD","BK1586","LU0254981946.USD","BK1555","02228","LU0791590937.USD","BK1590","00777","06821","02511","01762","81211","SG9999003461.SGD","00798","06060","LU0054237671.USD","LU0173614495.USD","02551","09860","LU0084288322.USD","01070","09961","01911","BK1607","BK1151","BK1095","IE00B29SXG58.USD","LU2506951792.HKD","00136","02197","LU1242518857.USD","BK1171","02533","LU0231483743.USD","BK1582","06086","LU0823437842.USD","BK1530","LU0823397285.USD","LU0384037296.USD","BK1219","BK1579","LU1831875114.USD","BK1224","BK1598","LU0499858438.USD","09880","01378","BK1615","09959","BK1148","02488","IE00BD6J9T35.USD","LU0831093199.SGD","LU0261947096.USD","IE00B8HQ1Z84.USD","LU2298064838.USD","02105","BK1175","LU0264606111.USD","IE0008368742.USD","86618","BYDDY","LU2460026573.USD","01471","SG9999000475.SGD","BK1500","SG9999002562.SGD","BK1519","LU1115378108.SGD","LU0823039010.USD","80992","01773","LU1951186391.HKD","BK1136","SG9999000418.SGD","SG9999006514.SGD","BK1140","BK1588","LNVGY","BK1154","BK1585","01877","00666","02587","BK1600","LU1046422090.SGD","LU2348774022.SGD","BK1605","BK1197","LU0865486749.SGD","LU1152091168.USD","00861","LU2125910500.SGD","LU0456846285.SGD","02670","IE00BGHQDM52.EUR","BK1186","SG9999002463.SGD","02382","LU1917777945.USD","LU2097828714.EUR","HK0000165453.HKD","00512","BK1131","LU0345775950.USD","BK1247","BK1137","BK1150","SGXZ90724238.SGD","LU2097828474.EUR","02400","BK1198","02013","BK1189","LU1808992512.USD","LU1719994722.HKD","01600","02431","LU0043850808.USD","LU0640798160.USD","02190","02436","01681","LU0531970944.HKD","02506","BK1596","LU0979878070.USD","LU0588545730.USD","IE0032431581.USD","BK1235","06160","BK1552","LU0594300179.USD","09956","BK1587","SG9999001093.SGD","LU1813983027.USD","01318","IE0031814852.USD","LU0261950983.USD","LU1508157978.USD","IE00BMCWC346.EUR","LU0274383008.USD","02498","LU0359202008.SGD","06963","00884","LU0082770016.SGD","BK1191","00300","06913","00020","BK1577","09992","BK1116","06058","02889","LU0143863198.USD","03939","BK1170","BK1184","LU0051755006.USD","LU2424517915.HKD","00867","HK0000320264.USD","LU1226288170.HKD","06613","02453","09985","02590","LU0049112450.USD","LU0329678337.USD","BK1523","02627","BK1132"],"gpt_icon":1},{"id":"1119835742","title":"Abbisko Cayman (02256) Releases Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1119835742","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119835742?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:08","pubTimestamp":1764752891,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (stock code: 02256) reported that, as of 30 November 2025, the authorized share capital remained at 5,000,000,000 ordinary shares with a par value of USD 0.00001 each, totaling...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2588086530","title":"Abbisko's IND Application for Cancer Therapy Cleared by U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2588086530","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588086530?lang=en_us&edition=fundamental","pubTime":"2025-12-02 12:04","pubTimestamp":1764648242,"startTime":"0","endTime":"0","summary":"Abbisko Cayman  said the U.S. Food and Drug Administration has cleared the investigational new drug application for ABSK141, its oral small-molecule KRAS G12D inhibitor, according to a Monday Hong Kong bourse filing.Shares of the drug company were down over 2% in Tuesday morning trade.The drug, developed by subsidiary Abbisko Therapeutics, is intended for treating patients with advanced solid tumours carrying KRAS G12D mutations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2488822045.USD","LU2476274308.USD","IE00B5MMRT66.SGD","LU2778985437.USD","BK1161","IND","LU2476274720.SGD","02256","IE00B543WZ88.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2588726520","title":"BRIEF-Abbisko Cayman Says U.S. FDA Clears IND Application For ABSK141","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726520","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726520?lang=en_us&edition=fundamental","pubTime":"2025-12-01 18:17","pubTimestamp":1764584273,"startTime":"0","endTime":"0","summary":"BRIEF-Abbisko Cayman Says U.S. FDA Clears IND Application For ABSK141Dec 1 (Reuters) - Abbisko Cayman Ltd 2256.HK:U.S. FDA CLEARS IND APPLICATION FOR ABBISKO'S ABSK141Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X701Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","BK1161","02256","LU2476274308.USD","LU2488822045.USD","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU2778985437.USD"],"gpt_icon":0},{"id":"1182686605","title":"ABBISKO-B (02256): FDA Approves IND Application for Oral Small Molecule KRAS G12D Inhibitor ABSK141","url":"https://stock-news.laohu8.com/highlight/detail?id=1182686605","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182686605?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:42","pubTimestamp":1764582149,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that its subsidiary, Shanghai Abbisko Biotechnology Co., Ltd., has received approval from the U.S. Food and Drug Administration (FDA) for the Investigational New Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IE00BPRC5H50.USD","LU2476274720.SGD","LU2476274308.USD","02256","LU2488822045.USD","IE00B5MMRT66.SGD","IND","IE00B543WZ88.USD","LU2778985437.USD"],"gpt_icon":0},{"id":"2588287723","title":"Abbisko Cayman - U.S. FDA Clears Ind Application for Abbisko's Absk141","url":"https://stock-news.laohu8.com/highlight/detail?id=2588287723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588287723?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:40","pubTimestamp":1764582011,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X701Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274720.SGD","BK1161","02256","LU2488822045.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2476274308.USD","LU2778985437.USD"],"gpt_icon":0},{"id":"2588872326","title":"Abbisko Therapeutics Wins FDA IND Clearance for KRAS G12D Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2588872326","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588872326?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:40","pubTimestamp":1764582004,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics, Subsidiary of Abbisko Cayman Ltd., Receives FDA IND Clearance for KRAS G12D Inhibitor ABSK141. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2jlp67:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","BK1161","LU2476274308.USD","IE00B543WZ88.USD","LU2488822045.USD","LU2476274720.SGD","IE00BPRC5H50.USD","LU2778985437.USD","02256"],"gpt_icon":0},{"id":"2587441760","title":"Is Abbisko Cayman Limited (HKG:2256) Trading At A 39% Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587441760","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587441760?lang=en_us&edition=fundamental","pubTime":"2025-11-30 08:02","pubTimestamp":1764460953,"startTime":"0","endTime":"0","summary":"Key Insights The projected fair value for Abbisko Cayman is HK$23.53 based on 2 Stage Free Cash Flow to Equity Abbisko...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/is-abbisko-cayman-limited-hkg2256-trading-at-a-39-discount","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/is-abbisko-cayman-limited-hkg2256-trading-at-a-39-discount","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2778985437.USD","BK1161","BK4100","BK4211","IE00B543WZ88.USD","LU2476274308.USD","LU2476274720.SGD","FCF","IE00BPRC5H50.USD","TV","DCF","IE00B5MMRT66.SGD","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"1123195689","title":"ABBISKO-B (02256) Rises Over 4% in Late Trading as It Presents Long-Term Efficacy and Safety Data of Pimicotinib in Phase III MANEUVER Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1123195689","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123195689?lang=en_us&edition=fundamental","pubTime":"2025-11-20 14:56","pubTimestamp":1763621782,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) surged over 4% in late trading, closing up 3.9% at HK$14.13 with a turnover of HK$45.41 million. The company announced that its subsidiary, Abbisko Therapeutics, presented long-term...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","IE00BPRC5H50.USD","02256","LU2488822045.USD","LU2476274308.USD","LU2778985437.USD","IE00B543WZ88.USD","BK1161","BK4134","LU2476274720.SGD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1216","BK1593","LU1634259557.SGD","BK1618","SG9999014674.SGD","02142","02171","BK1147","01651","SG9999015978.USD","00867","00861","02380","BK1109","BK1139","02453","BK1582","BK1575","BK1186","BK1228","02567","BK1500","BK1131","LU1522347837.USD","BK1171","BK1125","02177","09678","02587","BK1207","IE00BGHQDM52.EUR","LU2778985437.USD","BK1230","BK1529","02561","BK1137","BK1224","LU0348766576.USD","LU0348825331.USD","BK1110","BK1574","BK1539","LU1808992512.USD","IE00BVYPNP33.GBP","02858","01228","03145","BK1542","00826","09919","01809","BK1577","01773","09959","02670","03658","BK1104","BK1155","00003","00855","BK1225","02509","HK0000252152.HKD","02256","BK1161","00196","BK1178","06090","BK1592","BK1142","LU0348767384.USD","02268","BK1163","01333","BK1586","LU1497734951.SGD","BK1144","00604","09911","IE00B543WZ88.USD","LU2460026573.USD","BK1209","BK1595","SG9999015945.SGD","BK1609","BK1258","BK1531","BK1114","BK1552","BK1579","BK1191","02627","06100","06677","BK1578","SG9999015952.SGD","00305","BK1506","BK1585","01907","02886","06660","06996","BK1140","BK1524","BK1100","02488","LU1634259391.SGD","02431","SG9999003461.SGD","BK1556","BK1619","00290","IE00BMCWC346.EUR","06633","02551","02533","BK1202","00552","02096","01164","06608","BK1095","IE00BPRC5H50.USD","02167","LU2476274720.SGD","03315","IE00BYV24P56.USD","BK1591","BK1555","BK1527","BK1530","IE00BVYPNQ40.USD","02105","02157","06682","09860","BK1608","SG9999001069.SGD","00363","BK1521","BK1124","02279","BK1132","BK1229","BK1587","BK1175","LU2476274308.USD","SG9999002950.SGD","01969","00302","01762","BK1596","BK1116","01681","02511","BK1583","01167","02420","09996","09878","BK1516","03738","06919","BK1150","SG9999004220.SGD","02411","SG9999015986.USD","HK0000252160.HKD","BK1148","BK1141","BK1221","BK1183","BK1606","06069","BK1594","LU0417516902.SGD","00382","BK1219","01318","BK1518","00699","01783","06609","BK1194","HK0000500386.USD","IE00B5MMRT66.SGD","BK1188","LU1497733557.USD","BK1613","LU1497733631.SGD","BK1193","02616"],"gpt_icon":0},{"id":"1179822916","title":"Abbisko Cayman Limited (2256) Reports Longer-Term Efficacy and Safety Data for Pimicotinib Phase III Study in TGCT","url":"https://stock-news.laohu8.com/highlight/detail?id=1179822916","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179822916?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:22","pubTimestamp":1763338934,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (2256) announced that Abbisko Therapeutics, its subsidiary, presented longer-term efficacy, safety, and patient-reported outcomes from the global Phase III MANEUVER study of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"1199568114","title":"ABBISKO-B (02256): Subsidiary ABBISKO Presents Long-Term Efficacy and Safety Data of Pimicotinib Phase III MANEUVER Study at CTOS 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1199568114","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199568114?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:06","pubTimestamp":1763337978,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that its subsidiary, Shanghai ABBISKO Biopharmaceutical Co., Ltd. (ABBISKO), presented long-term efficacy, safety, and patient-reported outcome data from the global Phase...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","BK1161","CTOS","LU2476274308.USD","IE00B543WZ88.USD","BK1515","BK1574","LU2488822045.USD","III","LU2476274720.SGD","BK4104","02256","IE00BPRC5H50.USD","BK4134","LU2778985437.USD","09939","159938"],"gpt_icon":0},{"id":"2584691272","title":"Abbisko Cayman Reports Positive Long-Term Results for Pimicotinib in Phase III TGCT Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691272","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584691272?lang=en_us&edition=fundamental","pubTime":"2025-11-17 08:04","pubTimestamp":1763337843,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Ltd. announced that its subsidiary, Abbisko Therapeutics, presented longer-term efficacy and safety outcomes from the global Phase III MANEUVER study of pimicotinib  in patients with tenosynovial giant cell tumour  at the 2025 Connective Tissue Oncology Society  Annual Meeting. The analysis indicated that sustained treatment with pimicotinib led to continued improvements in tumor response and patient-reported outcomes including pain and function, while maintaining an acceptable safety profile. The company noted that while these results reinforce the potential for long-term use in eligible patients, there is no guarantee that ABSK021 will ultimately be successfully marketed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL81YQsV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU2488822045.USD","LU2778985437.USD","LU2476274720.SGD","02256","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1161","LU2476274308.USD"],"gpt_icon":0},{"id":"1119275750","title":"ABBISKO-B (02256) Completes First Patient Dosing in Phase II Clinical Trial of Oral Small-Molecule PD-L1 Inhibitor ABSK043 Combined with Golecerase for NSCLC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1119275750","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119275750?lang=en_us&edition=fundamental","pubTime":"2025-11-03 08:18","pubTimestamp":1762129096,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced on November 3, 2025, that its oral small-molecule PD-L1 inhibitor, ABSK043, in combination with golecerase—a KRAS G12C inhibitor developed by Shanghai Allist...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","LU1169589451.USD","BK1161","LU2488822045.USD","BK4023","PD","LU1169590202.USD"],"gpt_icon":0},{"id":"2580162237","title":"Abbisko Therapeutics Doses First Patient in Phase II NSCLC Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2580162237","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580162237?lang=en_us&edition=fundamental","pubTime":"2025-11-03 08:03","pubTimestamp":1762128199,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Ltd. announced that its subsidiary, Abbisko Therapeutics Co., Ltd., has completed first patient dosing in a phase II study of ABSK043, an oral small-molecule PD-L1 inhibitor, in combination with Glecirasib for the treatment of non-small cell lung cancer with KRAS G12C mutation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL5fyR4c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"1165802718","title":"Exploring the Depth and Breadth of ABBISKO-B's (02256) FIC/BIC Innovation Pipeline at R&D Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1165802718","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165802718?lang=en_us&edition=fundamental","pubTime":"2025-10-31 13:40","pubTimestamp":1761889233,"startTime":"0","endTime":"0","summary":"In recent years, ABBISKO-B (02256) has made significant strides in \"source innovation,\" leveraging its robust drug development capabilities, global clinical expertise, high-quality management...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"1164556215","title":"Guoyuan International Initiates Buy Rating on ABBISKO-B (02256) with Target Price of HK$22.06","url":"https://stock-news.laohu8.com/highlight/detail?id=1164556215","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164556215?lang=en_us&edition=fundamental","pubTime":"2025-10-29 11:06","pubTimestamp":1761707183,"startTime":"0","endTime":"0","summary":"Guoyuan International released a research report stating that ABBISKO-B (02256) is a leader in small-molecule innovative drugs. The firm forecasts revenues of RMB650 million, RMB680 million, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"1100490684","title":"Hong Kong Stock Movement | ABBISKO-B (02256) Surges Over 7% Amid Presentation of Pimicotinib Phase III Study Data at 2025 ESMO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1100490684","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100490684?lang=en_us&edition=fundamental","pubTime":"2025-10-27 10:06","pubTimestamp":1761530770,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) experienced a rise of over 7% during trading, currently up 6.06% at HKD 15.03, with a trading volume of HKD 9.1686 million. In recent news, ABBISKO-B announced that its subsidiary,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","LU2488822045.USD","BK4134","BK1161","02256"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}